May 8, 2018 / 8:12 AM / 16 days ago

BRIEF-Nestmedic Adopts 2018-2023 Strategy

May 8 (Reuters) - NESTMEDIC SA:

* ADOPTS 2018-2023 STRATEGY

* AS PART OF THE NEW STRATEGY, THE GROUP PLANS GRADUALLY ENTER SOME FOREIGN MARKETS

* IT HAS IDENTIFIED AROUND 20 MARKETS WHERE IT PLANS TO DEVELOP RELATIONS AND COOPERATION WITH LOCAL PARTNERS OVER 2018-2023 TO START DISTRIBUTION AND SALES OF PREGNABIT

* ITS RESEARCH AND DEVELOPMENT TEAM WILL CONTINUE R&D ACTIVITY TO IMPLEMENT PREGNABIT 2.0 SYSTEM, WHICH IS PLANNED TO BE RELEASED IN 2020

* AS PART OF THE STRATEGY, THE MANAGEMENT AIMS TO REACH 2018-2023 AGGREGATED REVENUE BETWEEN 149-307 MILLION ZLOTYS

* EBITDA MARGIN AT 50-60 PERCENT AT THE END OF 2023

* SHARE OF EXPORT IN THE COMPANY’S REVENUE AT OVER 90 PERCENT

Source text for Eikon:

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below